Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)

SHA:600329 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	31,071	20,699	22,121	18,246	19,473	11,199
Market Cap Growth	34.55%	-6.43%	21.24%	-6.30%	73.88%	23.50%
Enterprise Value	29,372	20,519	20,903	16,178	17,504	9,587
Last Close Price	46.49	29.64	31.14	26.35	27.80	15.30
PE Ratio	9.98	9.29	22.42	21.17	25.32	16.93
Forward PE	15.39	22.87	22.87	22.87	22.87	16.30
PS Ratio	5.79	2.83	2.69	2.21	2.82	1.70
PB Ratio	3.44	2.64	3.33	2.79	2.99	1.88
P/TBV Ratio	3.56	2.75	3.56	2.96	3.16	2.00
P/FCF Ratio	36.71	25.65	40.40	32.05	28.00	23.22
P/OCF Ratio	32.80	22.39	32.13	26.94	22.85	16.68
EV/Sales Ratio	5.47	2.81	2.54	1.96	2.53	1.45
EV/EBITDA Ratio	29.23	22.97	22.06	20.58	24.96	14.51
EV/EBIT Ratio	33.12	26.51	25.46	24.10	29.82	17.40
EV/FCF Ratio	34.70	25.43	38.17	28.42	25.17	19.88
Debt / Equity Ratio	0.00	0.01	0.05	0.04	0.01	0.01
Debt / EBITDA Ratio	0.02	0.04	0.36	0.34	0.06	0.06
Debt / FCF Ratio	0.02	0.05	0.62	0.47	0.06	0.09
Asset Turnover	0.48	0.70	0.81	0.86	0.80	0.82
Inventory Turnover	1.31	2.67	3.09	3.38	2.76	2.61
Quick Ratio	1.36	1.87	1.51	1.71	1.81	1.85
Current Ratio	2.81	2.35	2.03	2.17	2.64	2.59
Return on Equity (ROE)	46.11%	30.56%	14.68%	13.37%	12.63%	11.85%
Return on Assets (ROA)	4.92%	4.61%	5.03%	4.37%	4.23%	4.27%
Return on Capital (ROIC)	6.61%	6.50%	7.43%	6.27%	5.85%	5.96%
Return on Capital Employed (ROCE)	9.70%	9.70%	11.70%	9.80%	8.90%	9.00%
Earnings Yield	11.51%	10.77%	4.46%	4.72%	3.95%	5.91%
FCF Yield	2.72%	3.90%	2.48%	3.12%	3.57%	4.31%
Dividend Yield	2.75%	4.32%	4.11%	4.25%	1.80%	1.96%
Payout Ratio	28.19%	45.33%	88.91%	44.96%	30.17%	35.15%
Buyback Yield / Dilution	0.33%	-0.07%	0.71%	-0.94%	0.04%	0.37%
Total Shareholder Return	3.09%	4.25%	4.82%	3.31%	1.83%	2.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.